This is a Provisional Conference Programme.
For further information on this event please contact us.
Day One
Monday 22nd June 2026
09.15 Onwards
Registration, Coffee & Posters Set-Up
09.45-10.00
Welcome to SVS 2026 in Cork, Ireland
Professor Anne Moore
(University College Cork, Cork, Ireland)
SESSION 1:
PLENARY SESSION
Moderator: Anne Moore
(University College Cork, Cork, Ireland)
10.00-10.30
‘Skin Vaccination for outbreak response’
Renske Hesselink
(CEPI, Oslo, Norway)
10.30-11.00
‘Thermostable, adjuvant-free microneedle patch for human papillomavirus vaccination’
Mark Prausnitz
(Georgia Tech, Atlanta, Georgia, USA)
11.00-11.30
‘Beyond delivery: Dissolving microneedles as physical adjuvants for skin vaccination’
Hyungil Jung
(Yonsei University, Seoul, Republic of Korea / Juvic Inc., Seoul, Republic of Korea)
11.30-12.00
‘Microneedle and intramuscular immunization with VLP-based vaccines induces high IgG antibody titers in dermal interstitial fluid’
Alex Francian, Srinivasa R. Gadam, Aidan Leyba, Robert M. Taylor, Pavan Muttil, Justin T. Baca and Bryce Chackerian
(University of New Mexico School of Medicine, Albuquerque, New Mexico, USA)
12.00-13.15
Lunch Break & Posters
SESSION 2:
PLENARY SESSION
Moderator: Mark Prausnitz
(Georgia Tech, Atlanta, Georgia, USA)
13.15-13.45
‘Superior efficacy of a skin-applied microprojection device for delivering a novel Zika DNA vaccine’
Jovin Choo and David Muller
(University of Queensland, St Lucia, Queensland, Australia)
13.45-14.15
‘Targeting skin dendritic cells to induce anti-tumor immunity
Part I: Intradermal delivery technologies’
Koen van der Maaden
(Leiden University Medical Center (LUMC), Leiden, The Netherlands)
14.15-14.45
‘A narrative review of implementation research on intradermal delivery methods for fractionated-dose inactivated poliomyelitis vaccine’
Paul LaBarre
(PharmaJet, Golden, Colorado, USA)
14.45-15.15
Tea Break & Posters
SESSION 3
Moderator: Koen van der Maaden
(Leiden University Medical Center (LUMC), Leiden, The Netherlands)
15:15-15:45
‘Lessons gained from translating vaccine microarray skin patches from mice to large animals’
Anne Moore
(University College Cork, Cork, Ireland)
15.45-16.15
‘Safety, reactogenicity and immunogenicity of inactivated rotavirus vaccine administered by a microneedle patch in phase 1 clinical trial: Interim analysis and commercialization pathways’
Baoming Jiang
(Division of Viral Diseases, Centers for Disease Control and Prevention (CDC) Atlanta, Georgia, USA)
SESSION 4
Open Panel Discussion A
Moderator: David Muller
(University of Queensland, St Lucia, Queensland, Australia)
Panel Members:
Koen van der Maaden
(Leiden University Medical Centre (LUMC), Leiden, The Netherlands)
Mark Prausnitz
(Georgia Tech, Atlanta, Georgia, USA)
Paul LaBarre
(PharmaJet, Golden, Colorado, USA)
16.15-17.15
‘Key Hurdles the Skin Vaccination Field is Experiencing’
17.15-17.45
SVS 2026 Welcome Drinks Reception & Poster Session
Sponsored by TEN BIO
Day Two
SESSION 5:
Moderator: David Muller
(University of Queensland, St Lucia, Queensland, Australia)
09.00-09.30
‘Targeting skin dendritic cells to induce anti-tumor immunity
Part II: Nanoparticulate vaccine design’
Koen van der Maaden
(Leiden University Medical Center (LUMC), Leiden, The Netherlands)
09.30-10.00
‘Nucleic acid vaccine delivery by piezoelectric microneedle electroporation.’
Mark Prausnitz
(Georgia Tech, Atlanta, Georgia, USA)
10.00-10.30
‘HD-MAP delivered SARS-CoV-2 Spike protein vaccine is safe and immunogenic in healthy adults’
David Muller
(University of Queensland, St Lucia, Queensland, Australia)
10.30-11.30
Coffee Break & Posters
SESSION 6
Moderator: Koen van der Maaden
(Leiden University Medical Center (LUMC), Leiden, The Netherlands)
11.30-12.00
‘Results from an RCT evaluating the impact of needle-free intradermal delivery of inactivated polio vaccine in Nigeria’s routine immunization program’
Paul LaBarre
(PharmaJet, Golden, Colorado, USA)
12.00-12.30
’Acoustic vaccination: A needle-free approach to transdermal vaccine delivery’
Darcy Dunn-Lawless, Joel Balkaran, Abigail Collins, Brian Lyons, Constantin Coussios, Robert Carlisle and Michael Gray
(University of Oxford, Oxford, UK)
12.30-12.50
‘Ultrasound mediated non-invasive vaccination induces the induction of systemic and mucosal immunity’
Mark Unger
(muPharma, Malvern, Victoria, Australia)
12.50-14.00
Lunch Break & Posters
SESSION 7:
Moderator: Baoming Jiang
(Centers for Disease Control and Prevention (CDC) Atlanta, Georgia, USA)
14.00-14.30
‘Immune System Activation with Intradermal Needle-Free Vaccine Delivery: Preclinical Studies’
Alexa Carl, Kira Elma, Shaily Garg and Carmen Ledesma-Feliciano
(PharmaJet Inc., Golden, Colorado, USA)
14.30-15.00
‘Preserved functional antibody responses to a live-attenuated rotavirus vaccine delivered by microneedle patches with measles-rubella co-administration in rats’
Sung-Sil Moon1, Marly Richter-Roche2, Xiaoqian Wang1, Yuhuan Wang1, Theresa K. Resch1, Kimberly R. Foytich1, Elina El-Badry1, Sumathi Ramachandran1, Devin V. McAllister2 and Baoming Jiang1
( 1 Division of Viral Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA; 2 Micron Biomedical, INC., Atlanta, Georgia, USA)
15.00-15.30
‘The Geography of Immunity: Mapping the Enhanced Response to Microarray Patch Vaccination’
David Muller
(University of Queensland, St Lucia, Queensland, Australia)
15.30-16.00
Tea Break & Posters
SESSION 7 (Continued)
16.00-16.30
‘VAX-ID: Unlocking the potential of intradermal vaccination’
Nour Medjdoub
(Idevax BV, Antwerp, Belgium)
16.30-16.50
‘Recreating in vivo skin mechanics for reliable preclinical microneedle evaluation’
Michael Conneely
(Ten-Bio Ltd, Dundee, Scotland, UK)
SESSION 8
Open Panel Discussion B
Moderator: David Muller
(University of Queensland, St Lucia, Queensland, Australia)
Panel Members:
Renske Hesselink
(CEPI, Oslo, Norway)
Anne Moore
(University College UCC, Cork, Ireland)
16.50-17.30
‘Transdermal Vaccination: Manufacturing, Implementation, Harmonisation – where Next?’
Day Three
SESSION 9
Moderator: David Muller
(University of Queensland, St Lucia, Queensland, Australia)
09.30-10.00
‘Adjuvanted vaccines delivered to the skin by microneedles’
Lyndsey Moore and Anne Moore
(University College Cork, Cork, Ireland)
10.00-10.30
‘DNA vaccine delivery systems and microneedles’
Antonis Stylianou
(University of Nottingham, Nottingham, UK)
10.30-10.50
‘Restoring skin mechanics to preserve immune competency Ex Vivo’
Paul Campbell and Michael Conneely
(Ten-Bio Ltd/University of Dundee, Dundee, Scotland, UK)
10.50-11.20
Coffee Break & Posters
SESSION 10
Moderator: Mark Prausnitz
(Georgia Tech, Atlanta, Georgia, USA)
11.20-11.50
‘Fabrication of novel molecular-defined self-adjuvanting peptide containing dissolvable microneedles that are effectively used for cancer immunotherapy/or therapeutic cancer vaccination’
Beau van Hulst
(Leiden University Medical Centre, Leiden, The Netherlands)
11.50-12.20
‘Immune System Activation with Intradermal Needle-Free Vaccine Delivery: Clinical Studies’
Alexa Carl, Kira Elma, Shaily Garg and Carmen Ledesma-Feliciano
(PharmaJet Inc., Golden, Colorado, USA)
12.20-12.50
‘Impact of skin model and dissolvable microneedle design on efficiency of cutaneous protein delivery’
Lyndsey Moore
(University College Cork, Cork, Ireland)
12.50
SVS 2026 Conference Closing Remarks
Anne Moore
(University College Cork, Cork, Ireland)
Lunch & Departure
Posters
Poster 101
‘DNA vaccine delivery systems and microneedles’
Antonis Stylianou
(University of Nottingham, Nottingham, UK)
Poster 102
‘Candlelit-shaped space-inducing microneedles for potential skin barrier disruption and swelling-controlled delivery’
Ahhyun Lee1, Jaibyung Choi2, Suhyeon Shim2, Jiwoo Shin2, Jaan Strang3, Tobias Braun3, Reto Naef3, Hyungil Jung1,2,4
( 1 Department of Integrative Biotechnology, Yonsei University, Republic of Korea; 2 Department of Biotechnology, Yonsei University, Republic of Korea; 3 TOPADUR Pharma AG, Switzerland; 4 JUVIC Inc., Republic of Korea)
Poster 103
‘Route-dependent immunogenicity of dissolving microneedle vaccines: Superior mucosal immunity via sublingual delivery’
Youjin Lee1, Hye Su Min2, Eunju Jang3, Sung min Cho1, Jeehye Nam2, Serin Lee3, Youseong Kim, Jun Chang3, *, and Hyungil Jung2,4
( 1 Department of Integrative Biotechnology, Yonsei University 85, Songdogwahak-ro, Inchon, 21983 Republic of Korea Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seoul, 03722, Republic of Korea, 2 Department of Biotechnology, Yonsei University, 50 Yonsei-ro, Seoul, 03722, Republic of Korea, 3 Graduate School of Pharmaceutical Sciences, Ewha Womans University 52 Ewhayeodae-gil, Seoul 03760, Republic of Korea)
This provisional programme is correct at the time of publication. However the organizers reserve the right to make any alterations that may be required in the interests and integrity of the conference programme.